CORCEPT THERAPEUTICS INC — Director's Dealing 2021

May 13, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2021-05-11

Reporting Person: MAHONEY DAVID L (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-11	Common Stock	M	30000	$4.42	Acquired	118984	Direct
2021-05-11	Common Stock	F	6484	$20.45	Disposed	112500	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-11	Stock Option (Right to Buy)	$4.42	M	30000	Disposed	2021-05-19	Common Stock (30000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	112500	Indirect

Footnotes

F1: These shares were withheld so the Reporting Person could satisfy the exercise price arising from a net (cashless) exercise of stock options that occurred on May 11, 2021. The options subject to the net exercise were to expire on May 19, 2021.

F2: Fully exercisable.